Ani Balmanoukian
Safety and antitumour activity of durvalumab plus tremelimumab in non-small-cell lung cancer: a multicentre, phase 1b study
Scott Antonia, Sarah B Goldberg, Ani Balmanoukian, Jamie E Chaft, Rachel E Sanborn, Ashok Gupta, Rajesh Narwal, Keith Steele, Yu Gu, Joyson J Karakunnel, Naiyer A Rizvi
Lancet Oncol 2016; 17: 299–308
Published Online; February 5, 2016
http://dx.doi.org/10.1016/
S1470-2045(15)00544-6
